Skip to main content

Treatment of the Elderly Head and Neck Cancer Patient

  • Chapter
  • First Online:
Head and Neck Cancer

Abstract

Elderly patients represent at least 40% of head and neck squamous cell carcinoma (HNSCC). These patients often receive inadequate treatment, either exceeding their tolerance capability or exposing them to a lesser chance of cure because of undertreatment. Customizing treatment to the individual patient is the key for avoiding such pitfalls. This paper analyses the literature on optimal management of elderly patients with HNSCC, from the diagnostic procedures with a comprehensive geriatric assessment (CGA) of co-morbidities to the specific recommendations for surgery, radiotherapy, and chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al., editors. SEER Cancer Statistics Review, 1975–2006. Bethesda: National Cancer Institute; 2008.

    Google Scholar 

  2. Pignon T, Horiot JC, Van Den Bogaert W, Van Glabbeke M, Scalliet P. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer. 1996;32(12):2075–81.

    Article  Google Scholar 

  3. Horiot JC. Revisiting the concept of age limit in radiotherapy research protocols. Proceedings of the 5th meeting of the International Society of Geriatric Oncology; San Francisco; 2004. p. 91–93.

    Google Scholar 

  4. Horiot JC. Radiation therapy and the geriatric oncology patient. J Clin Oncol. 2007;25(14):1930–5.

    Article  PubMed  Google Scholar 

  5. Metges JP, Eschwège F, de Crevoisier R, et al. Radiotherapy in head and neck cancer in the elderly: a challenge. Crit Rev Oncol Hematol. 2000;34:195–203.

    Article  PubMed  CAS  Google Scholar 

  6. Schofield CP, Sykes AJ, Slevin NJ, et al. Radiotherapy for head and neck cancer in elderly patients. Radiother Oncol. 2003;69:37–42.

    Article  PubMed  Google Scholar 

  7. Zachariah B, Balducci L, Verkattaramanabalaji GV, et al. Radiotherapy for cancers aged 80 and older. A study of effectiveness and side effects. Int J Radiat Oncol Biol Phys. 1997;39:1125–9.

    Article  PubMed  CAS  Google Scholar 

  8. Italiano A, Ortholan C, Dassonville O, et al. Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival. Cancer. 2008;113:3160–8.

    Article  PubMed  Google Scholar 

  9. Ortholan C, Lusinchi A, Italiano A, et al. Oral cavity squamous cell carcinoma in 260 patients aged 80 years or more. Radiother Oncol. 2009;93:516–23.

    Article  PubMed  Google Scholar 

  10. Reizenstein JA, Bergström SN, Holmberg L, et al. Impact of age at diagnosis on prognosis and treatment in laryngeal cancer. Head Neck. 2009;32:1062–8.

    Article  Google Scholar 

  11. Extermann M. Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control. 2003;10:463–8.

    PubMed  Google Scholar 

  12. Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25:1824–31.

    Article  PubMed  Google Scholar 

  13. Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20:494–502.

    Article  PubMed  Google Scholar 

  14. Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005;55:241–52.

    Article  PubMed  Google Scholar 

  15. Rodin MB, Mobile SG. A practical approach to geriatric assessment in patients with cancer. J Clin Oncol. 2007;25:1936–44.

    Article  PubMed  Google Scholar 

  16. Sanabria A, Carvalho AL, Vartanian JG, et al. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol. 2007;14:1449–57.

    Article  PubMed  Google Scholar 

  17. Tran M, Raynard B, Bataillard A, Duguet A, Garabige V, Lallemand Y, et al. Standards, Options and Recommendations 2005 for a good practice in enteral nutrition in oncology (summary report). Bull Cancer. 2006;93:715–22.

    PubMed  Google Scholar 

  18. Horiot JC, Schraub S, Bone MC, et al. Dental preservation in patients irradiated for head and neck tumours: a 10 year experience with topical fluoride and a randomized trial between two fluoridation methods. Radiother Oncol. 1983;1:77–82.

    Article  PubMed  CAS  Google Scholar 

  19. Sanabria A, Carvalho AL, Melo R, et al. Predictive factors for complications in elderly patients who underwent oncologic surgery. Head Neck. 2008;30(2):170–7.

    Article  PubMed  Google Scholar 

  20. Pompei S, Tedesco M, Pozzi M, et al. Age as a risk factor in ­cervico-facial reconstruction. J Exp Clin Cancer Res. 1999;18:209–12.

    PubMed  CAS  Google Scholar 

  21. Ashley J, Duggan M, Sutcliffe N. Speech, language and swallowing disorders in older adult. Clin Geriartr Med. 2006;22:291–310.

    Article  Google Scholar 

  22. Werner JA, Dunne AA, Folz BJ, et al. Transoral laser microsurgery in carcinomas of the oral cavity, pharynx and larynx. Cancer Control. 2002;9:379–86.

    PubMed  Google Scholar 

  23. Audisio RA, Bozzetti F, Gennari R, et al. The surgical management of elderly cancer patients: recommendations of the SIOG surgical task force. Eur J Cancer. 2004;40:926–38.

    Article  PubMed  CAS  Google Scholar 

  24. Dubec JJ, Munk PL, Tsang V, et al. Carotid artery stenosis in patients who have undergone radiotherapy for head and neck malignancies. Br J Radiol. 1998;71:872–5.

    PubMed  CAS  Google Scholar 

  25. Brown PD, Foote RL, McLaughlin MP, et al. A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys. 2005;63:1361–7.

    Article  PubMed  Google Scholar 

  26. Falandry C, Tartouki K, Mornex F, et al. Is geriatric assessment adapted to radiotherapy? Cancer Radiothér. 2008;12:541–7.

    PubMed  CAS  Google Scholar 

  27. van Rij CM, Oughlane-Heemsbergen WD, Ackerstaff AH, Lamers EA, Balm AJM, Rasch CRN. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol. 2008;3:41.

    Article  PubMed  Google Scholar 

  28. Pignon JP, le Maître A, Bouhris J, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S112–4.

    Article  PubMed  Google Scholar 

  29. Bernier J. Current state-of-the-art for concurrent chemo-radiation. Semin Radiat Oncol. 2009;19:3–10.

    Article  PubMed  Google Scholar 

  30. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;88(13):890–9.

    Article  PubMed  CAS  Google Scholar 

  31. Lefebvre JL, Rolland F, Tesselaar M, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs. alternating chemotherapy and radiotherapy. J Natl Cancer Inst. 2009;101(3):142–52.

    Article  PubMed  CAS  Google Scholar 

  32. Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357(17):1695–704.

    Article  PubMed  CAS  Google Scholar 

  33. Fliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens. 2008;17:604–8.

    Article  PubMed  Google Scholar 

  34. Adelstein DJ, Ly Y, Adams JL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with resectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92–8.

    Article  PubMed  Google Scholar 

  35. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–44.

    Article  PubMed  Google Scholar 

  36. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91(24):2081–6.

    Article  PubMed  CAS  Google Scholar 

  37. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582–9.

    Article  PubMed  CAS  Google Scholar 

  38. Lokich J, Anderson N. Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann Oncol. 1998;9:13–21.

    Article  PubMed  CAS  Google Scholar 

  39. Wildiers H. Mastering chemotherapy dose reductions in elderly cancer patients. Eur J Cancer. 2007;43:2235–41.

    Article  PubMed  CAS  Google Scholar 

  40. Lichtman SM, Hollis D, Miller AA, et al. Prospective evaluation of the patient age and paclitaxel clinical pharmacology: cancer and leukemia group B (CALGB 9762). J Clin Oncol. 2006;24:1846–704.

    Article  PubMed  CAS  Google Scholar 

  41. Choi YJ, Chung J, Shin HJ, Cho GJ, et al. Induction chemotherapy of docetaxel and Cisplatin for the elderly patients with squamous cell carcinoma of the head and neck. Cancer Res Treat. 2007;39(1):1–5.

    Article  PubMed  Google Scholar 

  42. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567–78.

    Article  PubMed  CAS  Google Scholar 

  43. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11:21–8.

    Article  PubMed  CAS  Google Scholar 

  44. Athanassios A. EGFR antisense DNA added to cetuximab and radiotherapy for head and neck cancer. Grant 1R21CA130241-01A1 from National Cancer Institute.

    Google Scholar 

  45. Bernier J. Cetuximab: a standard approach to the first-line treatment of recurrent and/or metastatic and locally advanced squamous cell carcinoma of the head and neck. Oncol Rev. 2009;3:247–56.

    Article  Google Scholar 

  46. Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359:1116–27.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Claude Horiot .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Horiot, JC., Aapro, M.S. (2011). Treatment of the Elderly Head and Neck Cancer Patient. In: Bernier, J. (eds) Head and Neck Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9464-6_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9464-6_41

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9463-9

  • Online ISBN: 978-1-4419-9464-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics